Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis
- PMID: 28599217
- PMCID: PMC5645072
- DOI: 10.1016/j.neurobiolaging.2017.05.006
Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis
Abstract
Many theories of cognitive aging are based on evidence that dopamine (DA) declines with age. Here, we performed a systematic meta-analysis of cross-sectional positron emission tomography and single-photon emission-computed tomography studies on the average effects of age on distinct DA targets (receptors, transporters, or relevant enzymes) in healthy adults (N = 95 studies including 2611 participants). Results revealed significant moderate to large, negative effects of age on DA transporters and receptors. Age had a significantly larger effect on D1- than D2-like receptors. In contrast, there was no significant effect of age on DA synthesis capacity. The average age reductions across the DA system were 3.7%-14.0% per decade. A meta-regression found only DA target as a significant moderator of the age effect. This study precisely quantifies prior claims of reduced DA functionality with age. It also identifies presynaptic mechanisms (spared synthesis capacity and reduced DA transporters) that may partially account for previously unexplained phenomena whereby older adults appear to use dopaminergic resources effectively. Recommendations for future studies including minimum required samples sizes are provided.
Keywords: Dopamine; Healthy aging; Meta-analysis; Receptors; Synthesis capacity; Transporters.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
No authors have any actual or potential conflicts of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the work submitted that could inappropriately influence (bias) their work.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5645072/bin/nihms876437f6.gif)
Similar articles
-
Decreases in dopamine receptors but not in dopamine transporters in alcoholics.Alcohol Clin Exp Res. 1996 Dec;20(9):1594-8. doi: 10.1111/j.1530-0277.1996.tb05936.x. Alcohol Clin Exp Res. 1996. PMID: 8986209
-
There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.Brain Res Dev Brain Res. 1998 Nov 1;111(1):99-106. doi: 10.1016/s0165-3806(98)00126-6. Brain Res Dev Brain Res. 1998. PMID: 9804909
-
Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.Synapse. 2006 Mar 15;59(4):211-9. doi: 10.1002/syn.20234. Synapse. 2006. PMID: 16385509
-
Neurobiology of dopamine in schizophrenia.Int Rev Neurobiol. 2007;78:1-39. doi: 10.1016/S0074-7742(06)78001-1. Int Rev Neurobiol. 2007. PMID: 17349856 Review.
-
Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.Synapse. 2008 Nov;62(11):851-69. doi: 10.1002/syn.20566. Synapse. 2008. PMID: 18720516 Review.
Cited by
-
Dopamine D1-Receptor Organization Contributes to Functional Brain Architecture.J Neurosci. 2024 Mar 13;44(11):e0621232024. doi: 10.1523/JNEUROSCI.0621-23.2024. J Neurosci. 2024. PMID: 38302439 Free PMC article.
-
Association between body mass index (BMI) and [123I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography-computed tomography (SPECT-CT).Eur J Hybrid Imaging. 2023 Nov 20;7(1):21. doi: 10.1186/s41824-023-00181-6. Eur J Hybrid Imaging. 2023. PMID: 37981626 Free PMC article.
-
The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J.Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1012-1022. doi: 10.1007/s00259-023-06487-8. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37955791
-
A Pilot Study of the Striatal Dopamine Transporter Levels in Kratom-Dependent and Normal Subjects Using 99mTc-TRODAT-1 Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT).Cureus. 2023 Aug 10;15(8):e43251. doi: 10.7759/cureus.43251. eCollection 2023 Aug. Cureus. 2023. PMID: 37692587 Free PMC article.
-
Cerebrovascular integrity affects gradients of aging-related dopamine D1 differences in the striatum.Aging Brain. 2023 Aug 16;4:100094. doi: 10.1016/j.nbas.2023.100094. eCollection 2023. Aging Brain. 2023. PMID: 37645244 Free PMC article.
References
-
- Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266–271. - PubMed
-
- Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–381. - PubMed
-
- Bäckman L, Farde L. Dopamine and cognitive functioning: Brain imaging findings in Huntington’s disease and normal aging. Scand J Psychol. 2001;42:287–296. - PubMed
-
- Bäckman L, Ginovart N, Dixon RA, Wahlin TBR, Wahlin A, Halldin C, Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry. 2000;157:635–637. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical